Hematology in Clinical Practice最新文献

筛选
英文 中文
Herpes zoster infections: epidemiology, diagnostics, and prophylaxis in light of a growing clinical problem 带状疱疹感染:从日益严重的临床问题看流行病学、诊断和预防方法
Hematology in Clinical Practice Pub Date : 2024-03-18 DOI: 10.5603/hicp.96862
P. Własiuk, Krzysztof Giannopoulos
{"title":"Herpes zoster infections: epidemiology, diagnostics, and prophylaxis in light of a growing clinical problem","authors":"P. Własiuk, Krzysztof Giannopoulos","doi":"10.5603/hicp.96862","DOIUrl":"https://doi.org/10.5603/hicp.96862","url":null,"abstract":"","PeriodicalId":479826,"journal":{"name":"Hematology in Clinical Practice","volume":"21 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140231927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antithrombotic prophylaxis in patients treated with Bruton’s tyrosine kinase inhibitors 布鲁顿酪氨酸激酶抑制剂治疗患者的抗血栓预防作用
Hematology in Clinical Practice Pub Date : 2023-09-11 DOI: 10.5603/hcp.2023.0006
Sebastian Szmit
{"title":"Antithrombotic prophylaxis in patients treated with Bruton’s tyrosine kinase inhibitors","authors":"Sebastian Szmit","doi":"10.5603/hcp.2023.0006","DOIUrl":"https://doi.org/10.5603/hcp.2023.0006","url":null,"abstract":"There is an increased risk of atrial fibrillation in patients treated with Bruton’s tyrosine kinase inhibitors such as ibrutinib or acalabrutinib. The risk of this complication, as in the general population, increases with the age of patients and the coexistence of cardiovascular diseases. Due to the observed platelet dysfunction associated with the activity of ibrutinib, antithrombotic prophylaxis against stroke becomes an important clinical problem. The presence of potential interactions between ibrutinib and oral anticoagulant and additionally increased risk of bleeding determine specific therapeutic choices, which are described in the article.","PeriodicalId":479826,"journal":{"name":"Hematology in Clinical Practice","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136026262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信